Discover
BIAF
bioAffinity Technologies, Inc.
0.71
1 x 0.64
1 x 0.72
bid
ask
+
0.01
0.89%
60 @ 04:00 PM
0.72 +0.01 (1.97%)
| Ytd | -40.25% | |
| 1y | -93.56% |
0.69
day range
0.72
0.61
52 week range
13.50
| Open | 0.69 | Prev Close | 0.70 | Low | 0.69 | High | 0.72 | Mkt Cap | 3.19M |
| Vol | 128.05K | Avg Vol | 417.98K | EPS | -8.52 | P/E | -0.08 | Forward P/E | -1.58 |
| Beta | -1.11 | Short Ratio | 1.43 | Inst. Own | 3.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 1.27 | 200-d Avg | 1.80 | 1yr Est | 6.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-14 | 2024-09 | 0 | -0.16 | N/A | N/A |
| 2024-08-14 | 2024-06 | 0 | -0.19 | N/A | N/A |
| 2024-05-15 | 2024-03 | 0 | -0.21 | N/A | N/A |
| 2024-04-01 | 2023-12 | 0 | -0.26 | N/A | N/A |
| 2023-11-14 | 2023-09 | 0 | -0.26 | N/A | N/A |
| 2023-08-14 | 2023-06 | 0 | -0.2 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-07-23 | Maxim Group | Upgrade | Buy |
Profile
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-06-30 | ANDERSON ROBERT A | Director | 163.94K | Stock Award(Grant) |
| 2024-06-30 | DIAMOND STUART | Director | 99.09K | Stock Award(Grant) |
| 2024-11-04 | EDWARDS JAMES MICHAEL | Chief Financial Officer | 113.96K | Stock Award(Grant) |
| 2024-06-30 | GIRGENTI STEVEN | Officer and Director | 1.07M | Stock Award(Grant) |
| 2024-06-30 | JOYCE ROBY | Director | 649.75K | Stock Award(Grant) |
| 2024-06-30 | KNIGHT PETER S | Director | 117.46K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Group Inc | 260.87K | 247.83K | 1.67% |
| 2024-09-29 | Geode Capital Management, LLC | 87.18K | 82.82K | 0.56% |
| 2024-09-29 | Captrust Financial Advisors | 27.89K | 26.49K | 0.18% |
| 2024-09-29 | Sheaff Brock Investment Advisors, LLC | 20.00K | 19.00K | 0.13% |
| 2024-09-29 | State Street Corporation | 17.60K | 16.72K | 0.11% |
| 2024-09-29 | Northern Trust Corporation | 13.66K | 12.98K | 0.09% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 220.23K | 209.22K | 1.41% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 47.31K | 44.95K | 0.30% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 40.64K | 38.61K | 0.26% |
| 2024-10-30 | Fidelity Total Market Index Fund | 13.70K | 13.02K | 0.09% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 11.54K | 10.96K | 0.07% |
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 9.41K | 8.94K | 0.06% |
Split
| Split | Date |
|---|---|
| 1 : 30 | 2025-09-19 |